Apparatus Two-Drug Combination For Refractory Thyroid Cancer, 100% Effective! Jul 06, 2023 Jul 06, 2023 Data from a study presented at the annual meeting of the European Society of Medical Oncology in 2022 showed that lenvatinib in combination with Pembrolizumab could give 100% efficacy in this group of patients.
